Table 1.
Demographics, genotype and phenotype characteristics, and baseline functional assessment.
Variable | Level | Total (n = 19) |
---|---|---|
Age | Mean (Std) (min, max) | 39.7 (13.9) (21.3, 64.8) |
Sex | Women | 12 (63.2%) |
Men | 7 (36.8%) | |
SMN2 copies | 2 | 1 (5.3%) |
3 | 16 (84.2%) | |
4 | 2 (10.5%) | |
Age of onset (months) | Mean (Std) (min, max) | 27 (34) (2–156) |
SMA type | 2 | 9 (47%) |
3 | 10 (53%) | |
Age at loss of ambulation (SMA 3) (years) | Mean (Std) (min, max) | 25.8 (18.3) (8, 57) |
Baseline SMA-FRS | Mean (Std) (min, max) | 11.2 (10) (0, 30) |
Baseline hammersmith | Mean (Std) (min, max) | 3.5 (5.7) (0, 18) |
Baseline RULM | Mean (Std) (min, max) | 12.4 (11.5) (0, 37) |